- Posted: 04/07/16
Arrayjet, is proud to announce that we have secured a $400,000AUD contract with one of Australia’s flagship biomedical research institutes, housing some of the
country’s most renowned research groups in developing the next generation of
drugs and vaccines to fight diseases of global significance and impact.
- Posted: 22/04/16
Arrayjet have launched a pioneering in-house consultancy service designed to meet the needs of research laboratories across the globe requiring an outsourced fully time-scaled microarray printing facility.
- Posted: 16/03/16
Arrayjet are proud to win a £350,000 order from a Chinese life sciences company that produces detection kits for conditions including infant deafness, Down’s syndrome and thalassemia, a blood disorder that can cause anaemia.Arrayjet is a Roslin, Midlothian-based firm, which already exports to 24 countries, announced the top end Ultra Marathon I printer order with Beijing-based CapitalBio, a major government-backed life sciences business that specialises in looking for genetic mutations in DNA. A million babies in China have been screened with its genetic hearing loss detection kit.
Arrayjet Proudly Secure Contract with a Tobacco Giant to Assist Scientific Research Into ‘Harm Reduction’ Products
- Posted: 16/02/16
Arrayjet have won a £150,000 contract with Neuchâtel, Switzerland-headquartered, Philip Morris Products, SA (PMP), a wholly-owned subsidiary of Philip Morris International, Inc. (PMI), the world’s leading tobacco company.